Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-061119
Filing Date
2025-04-30
Accepted
2025-04-30 16:30:13
Documents
1
Period of Report
2025-04-30

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3204
  Complete submission text file 0000950170-25-061119.txt   4636
Mailing Address 3 SOMERSET DRIVE SOUTH GREAT NECK NY 11020
Business Address
PAPADOPOULOS STELIOS (Reporting) CIK: 0001202098 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35670 | Film No.: 25895913

Mailing Address 4224 CAMPUS POINT COURT SUITE 210 SAN DIEGO CA 92121
Business Address 4224 CAMPUS POINT COURT SUITE 210 SAN DIEGO CA 92121 858-202-6300
Regulus Therapeutics Inc. (Issuer) CIK: 0001505512 (see all company filings)

EIN.: 264738379 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)